Zhiyi Xu

840 total citations
21 papers, 680 citations indexed

About

Zhiyi Xu is a scholar working on Molecular Biology, Transportation and Immunology. According to data from OpenAlex, Zhiyi Xu has authored 21 papers receiving a total of 680 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Transportation and 5 papers in Immunology. Recurrent topics in Zhiyi Xu's work include Immune Cell Function and Interaction (4 papers), Immunotherapy and Immune Responses (4 papers) and Traffic and Road Safety (4 papers). Zhiyi Xu is often cited by papers focused on Immune Cell Function and Interaction (4 papers), Immunotherapy and Immune Responses (4 papers) and Traffic and Road Safety (4 papers). Zhiyi Xu collaborates with scholars based in China, United States and United Kingdom. Zhiyi Xu's co-authors include Xinyu Cao, Frank Douma, Yingling Fan, Xize Wang, Steve Hankey, Yujiang Fan, Greg Lindsey, Junhui Sui, Xingdong Zhang and Yong Sun and has published in prestigious journals such as Biomaterials, ACS Applied Materials & Interfaces and Free Radical Biology and Medicine.

In The Last Decade

Zhiyi Xu

20 papers receiving 659 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhiyi Xu China 13 270 139 117 80 68 21 680
Jieping Li China 16 251 0.9× 300 2.2× 44 0.4× 34 0.4× 25 0.4× 74 1.0k
Jinpei Li China 11 114 0.4× 53 0.4× 22 0.2× 10 0.1× 16 0.2× 24 371
Finn Jørgensen Norway 17 103 0.4× 337 2.4× 62 0.5× 3 0.0× 29 0.4× 33 772
Wenlong Zheng China 14 34 0.1× 154 1.1× 8 0.1× 48 0.6× 6 0.1× 37 524
Haitao Jin China 16 130 0.5× 68 0.5× 23 0.2× 13 0.2× 5 0.1× 43 651
Meixu Chen China 19 84 0.3× 140 1.0× 35 0.3× 129 1.6× 1 0.0× 52 770
Juan Song China 18 28 0.1× 365 2.6× 26 0.2× 15 0.2× 15 0.2× 49 987
Chunan Wang China 14 115 0.4× 16 0.1× 31 0.3× 30 0.4× 8 0.1× 37 429
Jianhong Ye China 17 298 1.1× 265 1.9× 66 0.6× 1 0.0× 116 1.7× 52 896
Zhansheng Zhang China 15 50 0.2× 147 1.1× 17 0.1× 3 0.0× 11 0.2× 51 613

Countries citing papers authored by Zhiyi Xu

Since Specialization
Citations

This map shows the geographic impact of Zhiyi Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhiyi Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhiyi Xu more than expected).

Fields of papers citing papers by Zhiyi Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhiyi Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhiyi Xu. The network helps show where Zhiyi Xu may publish in the future.

Co-authorship network of co-authors of Zhiyi Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Zhiyi Xu. A scholar is included among the top collaborators of Zhiyi Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhiyi Xu. Zhiyi Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jiang, Chen, et al.. (2025). Supramolecular carrier-free biological nanofibers for treatment of liver fibrosis. Colloids and Surfaces A Physicochemical and Engineering Aspects. 728. 138791–138791.
2.
Yao, Huan, Qian Xie, Yuanyuan Gong, et al.. (2022). Pretreatment with Panaxatriol Saponin Attenuates Mitochondrial Apoptosis and Oxidative Stress to Facilitate Treatment of Myocardial Ischemia‐Reperfusion Injury via the Regulation of Keap1/Nrf2 Activity. Oxidative Medicine and Cellular Longevity. 2022(1). 9626703–9626703. 48 indexed citations
3.
Yao, Huan, Yuanyuan Gong, Xueping Li, et al.. (2022). Panaxatriol saponin ameliorates myocardial infarction-induced cardiac fibrosis by targeting Keap1/Nrf2 to regulate oxidative stress and inhibit cardiac-fibroblast activation and proliferation. Free Radical Biology and Medicine. 190. 264–275. 54 indexed citations
4.
Xu, Zhiyi, Yang Xu, Xiaofang Xie, et al.. (2021). Anti-platelet aggregation of Panax notoginseng triol saponins by regulating GP1BA for ischemic stroke therapy. Chinese Medicine. 16(1). 12–12. 26 indexed citations
5.
Chen, Yafang, Mingda Zhao, Junhui Sui, et al.. (2021). Hierarchical responsive micelle facilitates intratumoral penetration by acid-activated positive charge surface and size contraction. Biomaterials. 271. 120741–120741. 21 indexed citations
6.
Wang, Lin, Xiulan Pu, Xin Nie, et al.. (2021). Integrated serum pharmacochemistry and network pharmacological analysis used to explore possible anti-rheumatoid arthritis mechanisms of the Shentong-Zhuyu decoction. Journal of Ethnopharmacology. 273. 113988–113988. 38 indexed citations
7.
Sui, Junhui, Mingda Zhao, Zhihao Guo, et al.. (2020). Acid-labile polysaccharide prodrug via lapatinib-sensitizing effect substantially prevented metastasis and postoperative recurrence of triple-negative breast cancer. Nanoscale. 12(25). 13567–13581. 12 indexed citations
8.
Sui, Junhui, Yani Cui, Hanxu Cai, et al.. (2017). Synergistic chemotherapeutic effect of sorafenib-loaded pullulan-Dox conjugate nanoparticles against murine breast carcinoma. Nanoscale. 9(8). 2755–2767. 43 indexed citations
9.
Cui, Yani, Junhui Sui, Zhiyi Xu, et al.. (2015). Reduction-Degradable Polymeric Micelles Decorated with PArg for Improving Anticancer Drug Delivery Efficacy. ACS Applied Materials & Interfaces. 8(3). 2193–2203. 35 indexed citations
10.
Hankey, Steve, et al.. (2012). Estimating use of non-motorized infrastructure: Models of bicycle and pedestrian traffic in Minneapolis, MN. Landscape and Urban Planning. 107(3). 307–316. 105 indexed citations
11.
Cao, Xinyu, et al.. (2012). Benefit and Cost Analysis of the I-394 MnPASS Program. University of Minnesota Digital Conservancy (University of Minnesota). 1 indexed citations
12.
Cao, Xinyu, Zhiyi Xu, & Arthur Huang. (2011). Safety Benefits of Converting HOV Lanes to HOT Lanes: Case Study of I-394 MNPass. ITE journal. 82(2). 32–37. 5 indexed citations
13.
Cao, Xinyu, Zhiyi Xu, & Frank Douma. (2011). The interactions between e-shopping and traditional in-store shopping: an application of structural equations model. Transportation. 39(5). 957–974. 127 indexed citations
14.
Cao, Xinyu, Zhiyi Xu, & Yingling Fan. (2010). Exploring the connections among residential location, self-selection, and driving: Propensity score matching with multiple treatments. Transportation Research Part A Policy and Practice. 44(10). 797–805. 98 indexed citations
15.
Cao, Xinyu, et al.. (2010). The Interactions between E-Shopping and Store Shopping: A Case Study of the Twin Cities. University of Minnesota Digital Conservancy (University of Minnesota). 4 indexed citations
16.
Xu, Zhiyi & Emmanuel Katsanis. (1997). Improved Immunostimulatory Function of Bone Marrow Derived Macrophages Transduced with the Granulocyte-Macrophage Colony Stimulating Factor Gene. Cancer Biotherapy and Radiopharmaceuticals. 12(1). 27–36. 1 indexed citations
17.
Katsanis, Emmanuel, Zhiyi Xu, Angela Panoskaltsis‐Mortari, et al.. (1996). IL-15 ADMINISTRATION FOLLOWING SYNGENEIC BONE MARROW TRANSPLANTATION PROLONGS SURVIVAL OF LYMPHOMA BEARING MICE1. Transplantation. 62(6). 872–875. 26 indexed citations
18.
Katsanis, Emmanuel, Zhiyi Xu, María A. Bausero, et al.. (1995). B7-1 expression decreases tumorigenicity and induces partial systemic immunity to murine neuroblastoma deficient in major histocompatibility complex and costimulatory molecules.. PubMed. 2(1). 39–46. 17 indexed citations
19.
20.
Katsanis, Emmanuel, Zhiyi Xu, Peter M. Anderson, et al.. (1994). Short-term ex vivo activation of splenocytes with anti-CD3 plus IL-2 and infusion post-BMT into mice results in in vivo expansion of effector cells with potent anti-lymphoma activity.. PubMed. 14(4). 563–72. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jieping Li Breakdown of academic impact, for papers by Jinpei Li Breakdown of academic impact, for papers by Finn Jørgensen Breakdown of academic impact, for papers by Wenlong Zheng Breakdown of academic impact, for papers by Haitao Jin Breakdown of academic impact, for papers by Meixu Chen Breakdown of academic impact, for papers by Juan Song Breakdown of academic impact, for papers by Chunan Wang Breakdown of academic impact, for papers by Jianhong Ye Breakdown of academic impact, for papers by Zhansheng Zhang
Rankless by CCL
2026